San Francisco Sentry Investment Group CA Sells 962 Shares of Thermo Fisher Scientific Inc. (TMO)

San Francisco Sentry Investment Group CA decreased its position in Thermo Fisher Scientific Inc. (NYSE:TMO) by 11.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,311 shares of the medical research company’s stock after selling 962 shares during the period. Thermo Fisher Scientific accounts for approximately 0.6% of San Francisco Sentry Investment Group CA’s investment portfolio, making the stock its 27th largest position. San Francisco Sentry Investment Group CA’s holdings in Thermo Fisher Scientific were worth $1,514,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of TMO. Millennium Management LLC grew its stake in shares of Thermo Fisher Scientific by 1,711.5% in the 1st quarter. Millennium Management LLC now owns 599,623 shares of the medical research company’s stock valued at $123,798,000 after buying an additional 566,523 shares during the period. Summit Trail Advisors LLC grew its stake in shares of Thermo Fisher Scientific by 17,587.1% in the 1st quarter. Summit Trail Advisors LLC now owns 544,587 shares of the medical research company’s stock valued at $545,000 after buying an additional 541,508 shares during the period. BlackRock Inc. grew its stake in shares of Thermo Fisher Scientific by 2.0% in the 1st quarter. BlackRock Inc. now owns 24,582,453 shares of the medical research company’s stock valued at $5,075,294,000 after buying an additional 475,267 shares during the period. Bank of Montreal Can purchased a new stake in shares of Thermo Fisher Scientific in the 2nd quarter valued at approximately $95,849,000. Finally, Chevy Chase Trust Holdings Inc. purchased a new stake in shares of Thermo Fisher Scientific in the 2nd quarter valued at approximately $70,775,000. 85.88% of the stock is owned by institutional investors and hedge funds.

Thermo Fisher Scientific opened at $231.42 on Friday, Marketbeat reports. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.58 and a quick ratio of 1.11. The company has a market cap of $93.95 billion, a P/E ratio of 22.53, a P/E/G ratio of 1.70 and a beta of 1.13. Thermo Fisher Scientific Inc. has a fifty-two week low of $170.07 and a fifty-two week high of $236.29.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings data on Wednesday, July 25th. The medical research company reported $2.75 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.63 by $0.12. The firm had revenue of $6.08 billion during the quarter, compared to analysts’ expectations of $5.90 billion. Thermo Fisher Scientific had a net margin of 10.36% and a return on equity of 16.28%. The firm’s quarterly revenue was up 21.8% on a year-over-year basis. During the same quarter last year, the company posted $2.30 EPS. equities analysts forecast that Thermo Fisher Scientific Inc. will post 10.98 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, October 15th. Investors of record on Monday, September 17th will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Friday, September 14th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.29%. Thermo Fisher Scientific’s payout ratio is currently 7.17%.

Several analysts have recently weighed in on TMO shares. Morgan Stanley increased their price target on shares of Thermo Fisher Scientific from $216.00 to $230.00 and gave the company an “overweight” rating in a research note on Thursday, April 26th. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $240.00 price target for the company in a research note on Monday, April 30th. ValuEngine cut shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research note on Wednesday, June 20th. JPMorgan Chase & Co. reissued an “overweight” rating and issued a $300.00 price target on shares of Thermo Fisher Scientific in a research note on Thursday, July 26th. Finally, Leerink Swann increased their price target on shares of Thermo Fisher Scientific from $239.00 to $255.00 and gave the company an “outperform” rating in a research note on Thursday, July 26th. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $239.08.

In related news, CEO Marc N. Casper sold 50,000 shares of the stock in a transaction that occurred on Wednesday, June 13th. The shares were sold at an average price of $217.71, for a total transaction of $10,885,500.00. Following the completion of the transaction, the chief executive officer now owns 272,122 shares of the company’s stock, valued at approximately $59,243,680.62. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Patrick M. Durbin sold 20,550 shares of the stock in a transaction that occurred on Wednesday, August 1st. The stock was sold at an average price of $233.87, for a total transaction of $4,806,028.50. The disclosure for this sale can be found here. Insiders have sold a total of 168,256 shares of company stock valued at $37,629,201 in the last ninety days. 0.49% of the stock is currently owned by corporate insiders.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Featured Story: Price to Earnings Ratio (PE)

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply